Compare Hut 8 Corp (HUT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hut 8 Corp vs Recursion Pharmaceuticals Inc — how do they compare? Hut 8 Corp trades at $92.75 (market cap $10.94B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Hut 8 Corp is far larger — about 6× Recursion Pharmaceuticals Inc's market cap, and Hut 8 Corp is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| HUT | RXRX | |
|---|---|---|
Market Cap | $10.94B | $1.81B |
Sector | Technology | Health |
52-Week High | $133.02 | $6.79 |
52-Week Low | $21.37 | $2.84 |
Enterprise Value | $18.38B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
